BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Doxycycline
,
rs2476601
,
ERBB2
,
G-protein-coupled receptor binding
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IFN) alpha
Summary
General Info
Curated Studies
Most Correlated Studies
Hematopoetic stem cells treated with IFN-alpha
Calu-3 cells responses to treatment with either IFN alpha or gamma
NIH-3T3 cells expression profile after IFN alpha and gamma treatment
Embryonic fibroblasts of mice treated with BCR-ABL inhibitor AMN107 and IFN-alpha or IFN-gamma
Hematopoietic stem cells from Jak2V617F mutant mice after treatment with IFN-alpha.
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition.
The pathogenic role of IFN-α in thyroiditis mouse models.
Antiviral Activity of Porcine IFN-λ3 and IFN-α against Porcine Rotavirus In Vitro.
IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases.
Molecular diversity and functional implication of amphibian interferon complex: Remarking immune ada…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in P…
Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ